Mr John Newton > Ropes & Gray > London, England > Lawyer Profile
- Firm Profile
- Go to...
Mr John Newton

Work Department
Private Equity
Position
Partner
Career
https://www.ropesgray.com/en/biographies/n/john-newton?AK=John%20Newt
Languages
English
Lawyer Rankings
London > Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
Ropes & Gray LLP continues to be instructed on a wide range of private equity mandates, acting for sponsors on acquisitions and disposals as well as handling investments. The practice is active in both the mid-market and high-value spaces. The team recently experienced several changes, with Kiran Sharma retiring in January 2022 and practice head Will Rosen going on secondment to Bain in the same month. This was followed in April by the addition of a number of PE partners from Fried, Frank, Harris, Shriver & Jacobson LLP, including Dan Oates and Simon Saitowitz. In addition to the new joiners, Helen Croke is a key figure in the team, with experience acting for a number of large and mid-cap PE funds, and John Newton wins praise from clients for his expertise in the healthcare sector. Elizabeth Todd is also well-regarded for her ability to ‘manage both the big picture and the details’.
Comparative Guides
United Kingdom: Private Equity | January 2023 | This country-specific Q&A provides an overview to Private Equity laws and regulations that may occur in United Kingdom. |
Lawyer Rankings
Top Tier Firm Rankings
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
Firm Rankings
- Finance > High yield
- Finance > Acquisition finance
- Real estate > Commercial property: investment
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
- Finance > Bank lending: investment grade debt and syndicated loans
- Corporate and commercial > Corporate tax
- Risk advisory > Data protection, privacy and cybersecurity
- Finance > Derivatives and structured products
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Real estate > Property finance
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory